Lornoxicam 8?mg ×?6 Ampoules Wholesale price comparison

Lornoxicam 8?mg ×?6 Ampoules Wholesale price comparison

$8.60

Lornoxicam is a potent oxicam?class NSAID with rapid onset and short half-life, used in preclinical pain and inflammation research. Each ampoule contains 8?mg for IV/IM use. Manufactured by Harbin Sanlian Pharmaceutical Co., Ltd., approval under NMPA H20057160, product code 86903662001906.
?? For laboratory research use only.?Please consult the staff for other purposes?

EMI starting from $0.00/month - View Plans
Compare

Description

Product Specifications

AttributeDetails
Product NameLornoxicam Injection (Harasanlian®)
Generic NameLornoxicam (Chlortenoxicam)
CAS Number70374?39?9 caymanchem.com+1targetmol.com+1
Molecular FormulaC??H??ClN?O?S?
Molecular Weight~371.8?g/mol
Dosage FormSolution for IV/IM Injection
Strength8?mg per ampoule
Pack Size6 ampoules per box
Approval NumberH20057160 (China NMPA)
Product Code86903662001906
ManufacturerHarbin Sanlian Pharmaceutical Co., Ltd.
StorageStore at 2–8?°C, protect from light
Intended UseLaboratory research use only

Mechanism of Action

Lornoxicam non-selectively inhibits COX-1 and COX-2, reducing prostaglandin synthesis to alleviate inflammation, pain, and fever. Notably, it has a relatively short elimination half-life (3–5?hrs), potentially leading to improved tolerability sciencedirect.com+15pubmed.ncbi.nlm.nih.gov+15link.springer.com+15.


Research Applications & Pharmacology

  • Acute & postoperative pain models: Injection (4–8?mg) provides analgesia comparable to morphine or tramadol.

  • Inflammatory disease studies: Effective in arthritis, osteoarthritis, and ankylosing spondylitis models.

  • Renal colic and musculoskeletal pain: Rapid VAS reduction, effective within 30 minutes.

  • Pharmacokinetics: Rapid absorption, high protein binding, hepatic metabolism to 5??hydroxy?lornoxicam, excreted via urine/feces.


Safety Profile & Handling

  • Adverse events: Mostly mild GI disturbances; rare serious effects like bleeding or bronchospasm.

  • Administration risk: Monitor for hypotension and renal function during studies.

  • Handling: Use PPE; reconstitute under sterile conditions; dispose of as pharmaceutical waste.


?? Research?Use Disclaimer

This product is designed exclusively for laboratory research. It is not approved for therapeutic, diagnostic, clinical, or veterinary applications. Misuse may present health risks and compromise experimental integrity.

Additional information

Weight1.1 kg
Dimensions18 × 16 × 18 cm

Reviews

There are no reviews yet.

Be the first to review “Lornoxicam 8?mg ×?6 Ampoules Wholesale price comparison”

Your email address will not be published. Required fields are marked *

EMI Options

Select at least 2 products
to compare